Collegium Pharmaceutical (FRA:354) Other Long Term Assets : €102.6 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Collegium Pharmaceutical Other Long Term Assets?

Collegium Pharmaceutical's other long-term assets for the quarter that ended in Dec. 2024 was €102.6 Mil.

Collegium Pharmaceutical's quarterly other long-term assets increased from Jun. 2024 (€33.5 Mil) to Sep. 2024 (€70.0 Mil) and increased from Sep. 2024 (€70.0 Mil) to Dec. 2024 (€102.6 Mil).

Collegium Pharmaceutical's annual other long-term assets increased from Dec. 2022 (€25.1 Mil) to Dec. 2023 (€25.8 Mil) and increased from Dec. 2023 (€25.8 Mil) to Dec. 2024 (€102.6 Mil).

Collegium Pharmaceutical Other Long Term Assets Historical Data

The historical data trend for Collegium Pharmaceutical's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Collegium Pharmaceutical Other Long Term Assets Chart

Collegium Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

2.19

71.40

25.11

25.80

102.61

Collegium Pharmaceutical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															25.80	30.06	33.53	70.03	102.61

Collegium Pharmaceutical Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Collegium Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Collegium Pharmaceutical Inc (FRA:354) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

COLL:USA

Address

100 Technology Center Drive, Stoughton, MA, USA, 02072

Website

https://www.collegiumpharma.com

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Collegium Pharmaceutical Headlines

No Headlines